Environmental Regulations May Create Barriers To Onshoring More Rx Manufacturing

 
• By Sarah Karlin-Smith

The House Ways and Means Committee may take more of a kitchen sink approach to addressing drug shortages than other congressional committees that have been primarily focused on paying for quality. Hearing witnesses said Congress must follow through on funding incentives for US onshoring. 

person working in drug manufacturing facility
Environmental challenges to onshoring as a drug shortage solution were discussed during a 6 February House Ways and Means Committee hearing. • Source: Shutterstock

More from Manufacturing

More from Compliance